• Je něco špatně v tomto záznamu ?

Instability of cerebrospinal fluid after delayed storage and repeated freezing: a holistic study by drop coating deposition Raman spectroscopy

J Klener, K Hofbauerova, A Bartos, J Ricny, D Ripova, V Kopecky

. 2014 ; 52 (5) : 657-664.

Jazyk angličtina Země Německo

Perzistentní odkaz   https://www.medvik.cz/link/bmc18035829

Grantová podpora
NT13183 MZ0 CEP - Centrální evidence projektů

BACKGROUND: The handling of cerebrospinal fluid (CSF) affects the biomarker quantification used to diagnose Alzheimer's disease (AD). Only specialized centers can test for AD markers. The precise timing and freezing is required to correctly measure these biomarkers. Therefore, the effects of CSF storage temperature and repeated freeze/thaw cycles on CSF stability were investigated. METHODS: Drop coating deposition Raman spectroscopy in combination with principal component analysis was used to analyze CSF and its dialyzed form (ELISA confirmed the removal of up to 80% of the AD markers). The advantage of this approach is that no prior knowledge of the biomarkers is necessary and that both the concentration and the protein structure of intact CSF are analyzed. RESULTS: Dialyzed CSF was stable for up to 5 h after its collection, while native CSF started to denature nearly immediately. Most of the unstable proteins were denatured within 24 h. The dialyzed CSF was not affected by freeze/thaw cycles, but the native CSF exhibited significant progressive changes, even after the first freezing. The mechanism as well as the resulting structures of the freeze-denatured proteins differed from those of the temporally denatured proteins, although both protein sets began with the same initial proteins. CONCLUSIONS: CSF must be processed immediately, within 5 h of collection. Flash cooling is recommended for freezing CSF, but any freeze/thaw cycle will affect the protein component of CSF.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18035829
003      
CZ-PrNML
005      
20220718134129.0
007      
ta
008      
181024s2014 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1515/cclm-2013-0800 $2 doi
035    __
$a (PubMed)24293450
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Klener J
245    10
$a Instability of cerebrospinal fluid after delayed storage and repeated freezing: a holistic study by drop coating deposition Raman spectroscopy / $c J Klener, K Hofbauerova, A Bartos, J Ricny, D Ripova, V Kopecky
520    9_
$a BACKGROUND: The handling of cerebrospinal fluid (CSF) affects the biomarker quantification used to diagnose Alzheimer's disease (AD). Only specialized centers can test for AD markers. The precise timing and freezing is required to correctly measure these biomarkers. Therefore, the effects of CSF storage temperature and repeated freeze/thaw cycles on CSF stability were investigated. METHODS: Drop coating deposition Raman spectroscopy in combination with principal component analysis was used to analyze CSF and its dialyzed form (ELISA confirmed the removal of up to 80% of the AD markers). The advantage of this approach is that no prior knowledge of the biomarkers is necessary and that both the concentration and the protein structure of intact CSF are analyzed. RESULTS: Dialyzed CSF was stable for up to 5 h after its collection, while native CSF started to denature nearly immediately. Most of the unstable proteins were denatured within 24 h. The dialyzed CSF was not affected by freeze/thaw cycles, but the native CSF exhibited significant progressive changes, even after the first freezing. The mechanism as well as the resulting structures of the freeze-denatured proteins differed from those of the temporally denatured proteins, although both protein sets began with the same initial proteins. CONCLUSIONS: CSF must be processed immediately, within 5 h of collection. Flash cooling is recommended for freezing CSF, but any freeze/thaw cycle will affect the protein component of CSF.
590    __
$a bohemika - dle Pubmed
650    02
$a Alzheimerova nemoc $x diagnóza $7 D000544
650    02
$a amyloidní beta-protein $x mok mozkomíšní $7 D016229
650    12
$a biologické markery $x mok mozkomíšní $7 D015415
650    12
$a zmrazování $7 D005615
650    02
$a lidé $7 D006801
650    02
$a analýza hlavních komponent $7 D025341
650    12
$a Ramanova spektroskopie $7 D013059
650    02
$a proteiny tau $x mok mozkomíšní $7 D016875
700    1_
$a Hofbauerová, Kateřina, $d 1974- $7 jo2004232787
700    1_
$a Bartoš, Aleš $7 xx0028753
700    1_
$a Říčný, Jan $7 xx0153151
700    1_
$a Řípová, Daniela, $d 1953- $7 xx0091955
700    1_
$a Kopecky V
773    0_
$t Clinical chemistry and laboratory medicine $g Roč. 52, č. 5 (2014), s. 657-664 $p Clin Chem Lab Med $x 1434-6621 $w MED00010886
773    0_
$p Clin Chem Lab Med $g 52(5):657-64, 2014 May
910    __
$a ABA008 $y 4 $z 0
990    __
$a 20181024132819 $b ABA008
991    __
$a 20220718134127 $b ABA008
999    __
$a ok $b bmc $g 1345509 $s 1032842
BAS    __
$a 3
BMC    __
$a 2014 $b 52 $c 5 $d 657-664 $x MED00010886 $i 1434-6621 $m Clinical chemistry and laboratory medicine
GRA    __
$a NT13183 $p MZ0
LZP    __
$a NLK 2018/lp

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...